KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2025)

Amneal Pharmaceuticals has reported Tax Rate over the past 9 years, most recently at 10.25% for Q4 2025.

  • Quarterly results put Tax Rate at 10.25% for Q4 2025, up 4565.0% from a year ago — trailing twelve months through Dec 2025 was 8.1% (up 4239.0% YoY), and the annual figure for FY2025 was 8.1%, up 4239.0%.
  • Tax Rate for Q4 2025 was 10.25% at Amneal Pharmaceuticals, down from 447.16% in the prior quarter.
  • Over the last five years, Tax Rate for AMRX hit a ceiling of 447.16% in Q3 2025 and a floor of 198.19% in Q3 2021.
  • Median Tax Rate over the past 5 years was 7.47% (2021), compared with a mean of 28.61%.
  • Biggest five-year swings in Tax Rate: skyrocketed 81333bps in 2021 and later plummeted -21878bps in 2023.
  • Amneal Pharmaceuticals' Tax Rate stood at 25.12% in 2021, then soared by 191bps to 22.98% in 2022, then plummeted by -152bps to 11.84% in 2023, then crashed by -199bps to 35.4% in 2024, then skyrocketed by 129bps to 10.25% in 2025.
  • The last three reported values for Tax Rate were 10.25% (Q4 2025), 447.16% (Q3 2025), and 31.14% (Q2 2025) per Business Quant data.